Triomed AB
PrivateLast Round
VC Round
Feb 24, 2016
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Triomed AB is a medical technology company that develops innovative therapeutic systems for peritoneal dialysis, including its proprietary Steady Concentration Peritoneal Dialysis (SCPD) method and the Carry Life UF platform.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triomed AB Comparables
Compare Triomed AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iRen-MEDICAL | 81% | |
| Vivance | 81% | |
| Nextkidney | 78% | |
Triomed AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 24, 2016 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 81% MoM, reaching 1K.
- May 15, 2026
Monthly visitors increased 605% MoM.
Triomed AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Triomed AB's valuation, stock price, and market status.